Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement

Background and objectives: Multiple reforms aimed at improving the Chinese population’s health have been introduced in recent years, including several designed to improve access to innovative drugs. We sought to review current factors affecting access to innovative drugs in China and to anticipate f...

Descripción completa

Detalles Bibliográficos
Autores principales: Macabeo, Bérengère, Wilson, Liam, Xuan, Jianwei, Guo, Ruichen, Atanasov, Petar, Zheng, Linda, François, Clement, Laramée, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266112/
https://www.ncbi.nlm.nih.gov/pubmed/37325810
http://dx.doi.org/10.1080/20016689.2023.2218633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266112/
https://www.ncbi.nlm.nih.gov/pubmed/37325810
http://dx.doi.org/10.1080/20016689.2023.2218633

Ejemplares similares